Mary Mosher

Array ( [id] => 6380455 [patent_doc_number] => 20100316667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'GENETICALLY STABLE RECOMBINANT MODIFIED VACCINIA ANKARA (RMVA) VACCINES AND METHODS OF PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/795621 [patent_app_country] => US [patent_app_date] => 2010-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 28249 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0316/20100316667.pdf [firstpage_image] =>[orig_patent_app_number] => 12795621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095404 [patent_doc_number] => 20110002958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'Alphavirus Vectors for Respiratory Pathogen Vaccines' [patent_app_type] => utility [patent_app_number] => 12/791140 [patent_app_country] => US [patent_app_date] => 2010-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 35218 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20110002958.pdf [firstpage_image] =>[orig_patent_app_number] => 12791140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6031090 [patent_doc_number] => 20110081368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'Protein vaccines against poxviruses' [patent_app_type] => utility [patent_app_number] => 12/802034 [patent_app_country] => US [patent_app_date] => 2010-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 20140 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20110081368.pdf [firstpage_image] =>[orig_patent_app_number] => 12802034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9085818 [patent_doc_number] => 08557241 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-15 [patent_title] => 'Secreted/cell bound poxvirus proteins and methods of use thereof as vaccines and anti-viral agents' [patent_app_type] => utility [patent_app_number] => 12/787792 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 26 [patent_no_of_words] => 37658 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12787792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6195516 [patent_doc_number] => 20110027270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'MONOCLONAL ANTIBODIES AGAINST INFLUENZA VIRUS GENERATED BY CYCLICAL ADMINISTRATION AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/788103 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 58733 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 35 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027270.pdf [firstpage_image] =>[orig_patent_app_number] => 12788103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6343622 [patent_doc_number] => 20100330112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'VACCINES AGAINST HERPES SIMPLEX VIRUS TYPE 2: COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 12/786425 [patent_app_country] => US [patent_app_date] => 2010-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 21619 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330112.pdf [firstpage_image] =>[orig_patent_app_number] => 12786425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6070163 [patent_doc_number] => 20110045013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'CAT Allergen Conjugates and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/785174 [patent_app_country] => US [patent_app_date] => 2010-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 20597 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20110045013.pdf [firstpage_image] =>[orig_patent_app_number] => 12785174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8409959 [patent_doc_number] => 08273354 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-25 [patent_title] => 'Anti-RSV G protein antibodies' [patent_app_type] => utility [patent_app_number] => 12/778933 [patent_app_country] => US [patent_app_date] => 2010-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 37 [patent_no_of_words] => 10788 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12778933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9245112 [patent_doc_number] => 08609392 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-17 [patent_title] => 'Method for orthopoxvirus production and purification' [patent_app_type] => utility [patent_app_number] => 13/319874 [patent_app_country] => US [patent_app_date] => 2010-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18048 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 202 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13319874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7555110 [patent_doc_number] => 08067010 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Immunological herpes simplex virus antigens and methods for use thereof' [patent_app_type] => utility [patent_app_number] => 12/777156 [patent_app_country] => US [patent_app_date] => 2010-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 19444 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067010.pdf [firstpage_image] =>[orig_patent_app_number] => 12777156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6024292 [patent_doc_number] => 20110052618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS' [patent_app_type] => utility [patent_app_number] => 12/769304 [patent_app_country] => US [patent_app_date] => 2010-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 27607 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052618.pdf [firstpage_image] =>[orig_patent_app_number] => 12769304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234924 [patent_doc_number] => 20100266628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'MACROCYCLIC LACTONE COMBINATION COMPOSITIONS, VACCINES AND METHODS FOR PRODUCING SAME' [patent_app_type] => utility [patent_app_number] => 12/759176 [patent_app_country] => US [patent_app_date] => 2010-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10545 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266628.pdf [firstpage_image] =>[orig_patent_app_number] => 12759176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9026103 [patent_doc_number] => 08535682 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-17 [patent_title] => 'Recombinant vaccine against West Nile Virus' [patent_app_type] => utility [patent_app_number] => 12/758500 [patent_app_country] => US [patent_app_date] => 2010-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 67 [patent_figures_cnt] => 67 [patent_no_of_words] => 30696 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12758500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10114639 [patent_doc_number] => 09149503 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-06 [patent_title] => 'Papillomavirus-like particles (VLP) as broad spectrum human papillomavirus (HPV) vaccines' [patent_app_type] => utility [patent_app_number] => 13/263563 [patent_app_country] => US [patent_app_date] => 2010-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 21343 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13263563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6187870 [patent_doc_number] => 20110171249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'Chimeric chikungunya virus and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/798796 [patent_app_country] => US [patent_app_date] => 2010-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9859 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171249.pdf [firstpage_image] =>[orig_patent_app_number] => 12798796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9575251 [patent_doc_number] => 08765666 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-01 [patent_title] => 'Adenovirus dodecahedron particles for delivery of pharmaceutical agents' [patent_app_type] => utility [patent_app_number] => 13/263632 [patent_app_country] => US [patent_app_date] => 2010-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7818 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13263632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6271060 [patent_doc_number] => 20100255029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'NEWCASTLE DISEASE VIRUS VECTORED AVIAN VACCINES' [patent_app_type] => utility [patent_app_number] => 12/753597 [patent_app_country] => US [patent_app_date] => 2010-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 61 [patent_no_of_words] => 27442 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20100255029.pdf [firstpage_image] =>[orig_patent_app_number] => 12753597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8435149 [patent_doc_number] => 08282917 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-09 [patent_title] => 'Mutant viruses and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/750410 [patent_app_country] => US [patent_app_date] => 2010-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 23 [patent_no_of_words] => 18840 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12750410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10007855 [patent_doc_number] => 09051359 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-09 [patent_title] => 'Influenza virus vaccines and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/750393 [patent_app_country] => US [patent_app_date] => 2010-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 60690 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12750393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9648100 [patent_doc_number] => 08802109 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-12 [patent_title] => 'Herpes simplex virus mutant ICP0' [patent_app_type] => utility [patent_app_number] => 12/749415 [patent_app_country] => US [patent_app_date] => 2010-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 75 [patent_no_of_words] => 29727 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12749415 [rel_patent_id] =>[rel_patent_doc_number] =>)